|
Groundbreaking Technology Solves
the Nitric Oxide Puzzle
Scientists
at MHP introduce new medical discoveries to optimize the extremely complex
NO pathway for maximum Nitric Oxide synthesis. Here is how…
The human
body has many built-in regulating systems of checks and balances. And
since Nitric Oxide is such a powerful compound, the Nitric Oxide pathway
is one of the most complex. While arginine is the “raw material”
used by the body to produce Nitric Oxide, there are many interactions
along the Nitric Oxide pathway which influence Nitric Oxide production.
The Nitric
Oxide biochemical pathway can be influenced by these various co-factors:
homocysteine, ADMA (asymmetric dimethylarginine), SOA (super oxide anion),
SOD (super oxide dimutase) and perhaps the most critical of all NOS (nitric
oxide synthase). The relationship between these co-factors has a direct
influence on the amount of arginine that can be converted (synthesized)
to Nitric Oxide. Remember, no matter how much arginine or arginine substrates
(i.e. AAKG, arginine malate, arginine ethyl ester) you feed your body,
the amount of Nitric Oxide you can produce is limited to these Nitric
Oxide pathway co-factors. The best way to explain it is that while arginine
is the fuel, these co-factors are the parts which make up the Nitric Oxide
engine.
Biofolin—The
spark that ignites the Nitric Oxide engine!
Biofolin
is an amazing newly discovered compound, patented by Merck KGaA Germany,
which has the unique ability to maximize the conversion of arginine to
NO by augmenting all of the co-factors involved in arginine’s conversion
to Nitric Oxide within the pathway. The discovery of Biofolin, a powerful,
novel compound, is regarded by many in the medical field as the biggest
breakthrough ever in inducing Nitric Oxide production. Biofolin is so
powerful, it is technically considered a drug even at low doses. And now,
it’s being made available to bodybuilders and athletes exclusively
in TRAC Extreme-NO.
|
